Antonia Syrigou
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.
Journal: The New England journal of medicine
Published: April 08, 2026
Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 24, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.
Journal: British journal of haematology
Published: January 17, 2025
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.
Journal: Frontiers in medicine
Published: May 20, 2023
Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
Journal: Leukemia & lymphoma
Published: August 24, 2022
Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change.
Journal: HemaSphere
Published: November 23, 2019
Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data.
Journal: Hematological oncology
Published: June 03, 2019
The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 23, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026